"We have taken biopharmaceuticals from early concept studies all the way to market approval."

Dr Derek Ellison

Chief Operating Officer

derek.ellison@edenbiodesign.com

Derek is responsible for the operational activities of Eden Biodesign, including Development, cGMP production, QC, client project management and maintaining Eden's state of the art facilities. Previously, Derek has led Eden Biodesign's commercial activities with responsibility for managing  global business development. Derek has extensive expertise in product development, having provided specialist analytical, technical transfer and regulatory consultancy and training to over 30 clients on behalf of Eden Biodesign.

Prior to this, Derek led the Protein Analytical Development Team at Celltech–Medeva and played a key role in the successful market approval of the company’s lead recombinant vaccine product. Before working in the biopharm industry and co–founding Eden Biodesign, Derek was a Post–Doctoral Researcher funded by the British Heart Foundation.